|
|
Physician Profile
Sydney S. Yoon, MD, co-chief of interventional radiology, completed his fellowship training at UCLA Medical Center with Scott Goodwin, MD who introduced fibroid embolization to the United States. Dr. Yoon has extensive experience in fibroid embolization and in other vascular and interventional procedures. He received his medical degree from the University of Chicago, completed his radiology residency at UCLA Medical Center and his medicine residency at the Johns Hopkins Hospital. Dr. Yoon is board certified in vascular & interventional radiology, diagnostic radiology and medicine, and is cited in the most recent "Best Doctors" issue in New York Magazine and in Castle Connolly's, "America's Top Doctors" and "Top Doctors-New York Metro Area".
Kenneth Crystal, MD, co-chief of interventional radiology, completed his fellowship training at NYU Medical Center. Dr. Crystal has extensive experience in fibroid embolization and in other vascular and interventional procedures. He received his medical degree at the University of Rochester, and completed his radiology residency at NYU. Dr. Crystal is board certified in vascular & interventional radiology, diagnostic radiology, and was formerly chief of interventional radiology at North Shore University Hospital and is a fellow in the Society of Cardiovascular & Interventional Radiology and cited in Castle Connolly's "Top Doctors-New York Metro Area".
Stephen Bravo, MD, chief of MRI, completed his fellowship training at Harvard's Brigham and Women's Hospital. Dr. Bravo has extensive experience in fibroid embolization and in other vascular and interventional procedures. He received his medical degree at Cornell Medical College, and completed his radiology residency at Brigham and Women's Hospital. He is board certified in diagnostic radiology, and was formerly attending interventional radiologist at Harvard's Brigham and Women's Hospital.
|
|
|
|
|
|
Contact us if you have any questions or to make an appointment to see any of our physicians:
Sydney S. Yoon, MD (516)562-6517,
Kenneth Crystal, MD (516)562-6509
Stephen Bravo, MD (516)562-6502
|
|
|
|
Introduction
Uterinefibroid.com is the web site for the Department of Radiology at St. Francis Hospital in Roslyn, NY. We are one of the leading centers in New York devoted to uterine fibroid embolization in the treatment of symptomatic uterine fibroids. We have the greatest experience in fibroid embolization in Long Island, having performed over 300 uterine artery embolizations. If you would like further information regarding fibroids and their treatment, you may contact us by calling the number at the end of the web site.
|
|
|
|
Fibroid embolization
Fibroid embolization, also known as uterine artery embolization, is a highly effective, safe and nonsurgical method of treating symptomatic fibroids. The procedure was first reported in the United States by Scott Goodwin, MD at UCLA Medical Center in 1996. While embolization of uterine fibroids has been performed in the United States for six years, uterine artery embolization is not new. The procedure has been performed for 23 years to treat heavy bleeding after childbirth or following motor vehicle accidents. As of the end of 2000, over 10,000 fibroid embolizations have been performed worldwide.
Effectiveness: Studies show that up to 94% of women have significant or complete relief of symptoms such as heavy menstrual bleeding, cramping, urinary pressure or frequency, and abdominal and pelvic distension. The procedure works regardless of the size or number of fibroids. No recurrences have been reported in women who have been followed up to six years. The average shrinkage in fibroid is 50% after 3 months and 70-80% after 1 year.
Safety: Fibroid embolization is a safe procedure. Serious complications such as infection or uterine injury requiring hysterectomy occur in less than 1% of patients. The complication rates are significantly less than that for hysterectomy or myomectomy. All devices, equipment and medications used for fibroid embolization are within FDA guidelines. The particles used for embolization, polyvinyl alcholol, is a standard agent for medical embolizations with a firmly established safety record. The xray fluoroscopy time is generally less than 10 minutes, on par with other angiographic procedures such as cardiac catherizations.
Nonsurgical: The procedure is performed through a 2mm skin puncture, not an incision. Because of the small size of the puncture, no visible mark is left on the skin after two weeks. No scarring occurs. Under xray guidance, a less than 2mm in diameter catheter is guided to the artery supplying the fibroid [uterine artery]. After confirming the position of the catheter, tiny gelatin particles are injected into the artery. This stops the blood flow to the fibroids, causing them to shrink. After an overnight stay in the hospital, patients go home and are back to work in 1 to 2 weeks.
Insurance: Most insurances cover uterine fibroid embolization.
|
|
|
